Funding to Support Preclinical Development of First-in-Class Inhaled Therapy Targeting Lung Inflammation and Fibrosis Cincinnati, OH, May 11, 2026 — IpiNovyx Bio, a biotechnology company developing best-in-class proteasome modulating therapeutics, and launched by Orange Grove Bio, today announced it has been selected to receive support from the National Heart, Lung, and Blood Institute’s (NHLBI) Catalyze
CINCINNATI, OH, August 12, 2025 – Orange Grove Bio, a biotech holding company focused on transforming and developing early, innovative ideas into pharma-ready therapies announces today that it has closed on a new round of financing led by a consortium of investors based in Denver, Colorado and effective immediately upon close Salvatore Cremona has been
With U.S. Blood Donations at a 20-Year Low, New Research Published in the Journal Blood Demonstrates How the Additive Could Extend Platelet Storage to 14 Days, Significantly Reducing Contamination Risk and Waste CINCINNATI, Ohio – August 21, 2024 – Preservation Bio, a leader in platelet preservation technology, today announced a major advancement in transfusion medicine,
NIH Grant to Accelerate Development of Innovative Non-Viral, Non-Lipid Platform Originating from Cincinnati Children’s CINCINNATI, Ohio, July 30, 2024 — Genexys BioMed, a pre-clinical stage biotechnology company developing a novel non-viral, non-lipid genetic medicine platform for the treatment of cystic fibrosis (CF) and other genetic diseases, announced today it has been awarded a $320,000 Phase
Collaboration Aims to Bridge the Gap Between Academic Research and Commercial Development, Fostering a Thriving Biotech Ecosystem in Chicago CINCINNATI, Ohio, July 23, 2024 — Orange Grove Bio, a leading integrated biopharmaceutical company, and the University of Chicago’s Polsky Center for Entrepreneurship and Innovation today announced a strategic partnership to catalyze the successful commercialization of
Partnership represents firm’s second international collaboration and provides access to groundbreaking research taking place within world’s fifth largest pharmaceutical market The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, January 31, 2023 (GLOBE NEWSWIRE) – Orange Grove Bio, a drug investment and development firm, today announced that it has established a new
The following excerpt was taken from dailyhunt.me — continue reading here. ABU DHABI, 19th October, 2023 (WAM) – Dr Thani bin Ahmed Al Zeyoudi, UAE Minister of State for Foreign Trade, has held a series of high-level meetings with global ministers on the fourth day of the 8th World Investment Forum (WIF), during which he
OGB Also Announces Key Appointments to Board of Senior Advisors and the Opening of New Headquarters The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, Sept. 28, 2023 (GLOBE NEWSWIRE) Orange Grove Bio (OGB), a drug investment and development firm, today announced that Preservation Bio, one of the firm’s majority-owned subsidiaries, has been
Collaborations with Yonsei University Health System and Pohang University of Science and Technology Designed to Strengthen Biotech Entrepreneurial Ecosystem in South Korea The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio Expands Academic Collaboration Activities Internationally Through New Strategic Partnerships CINCINNATI, March 23, 2023 (GLOBE NEWSWIRE) — Orange Grove Bio, a
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration to Strengthen Biotech Ecosystem and Support Development and Commercialization of Novel Therapeutics The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio, a drug investment and development firm, today announced the establishment of a strategic collaboration with the Magnuson